- Boulanger-Piette A, Bergeron J, Desgreniers J, Cote-Levesque M, Brassard D, Joanisse DR, et al. [Statin intolerance and associated muscular dysfunctions]. Med Sci (Paris). 2015;31(12):1109-14.
- Ueda P, Lung TW, Lu Y, Salomon JA, Rahimi K, Clarke P, et al. Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England. PLoS One. 2018;13(3):0190688.
- Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016;83(1):37-42.
- Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ. Statin-induced myopathies. Pharmacol Rep. 2011;63(4):859-66.
- Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292(21):2585-90.
- Arora R, Liebo M, Maldonado F. Statin-induced myopathy: the two faces of Janus. J Cardiovasc Pharmacol Ther. 2006;11(2):105-12.
- El-Gamal DA, Ahmed SF. Effect of green tea on aged rat skeletal muscle: a light and electron microscopic study. Egypt J Histol. 2012;35(2).
- Gissler MC, Anto-Michel N, Pennig J, Scherrer P, Li X, Marchini T, et al. Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in Mice. Arterioscler Thromb Vasc Biol. 2021;41(10):2563-74.
- Ruano G, Seip R, Windemuth A, Wu AH, Thompson PD. Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins. Clin Lab Med. 2016;36(3):473-91.
- Anto Michel N, Colberg C, Buscher K, Sommer B, Pramod AB, Ehinger E, et al. Inflammatory Pathways Regulated by Tumor Necrosis Receptor-Associated Factor 1 Protect From Metabolic Consequences in Diet-Induced Obesity. Circ Res. 2018;122(5):693-700.
- Basu D, Hu Y, Huggins LA, Mullick AE, Graham MJ, Wietecha T, et al. Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor. Circ Res. 2018;122(4):560-7.
- Schaefer WH, Lawrence JW, Loughlin AF, Stoffregen DA, Mixson LA, Dean DC, et al. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicol Appl Pharmacol. 2004;194)1(:10-23.
- Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther. 2007;29(2):253-60.
- Eng CM, Smallwood LH, Rainiero MP, Lahey M, Ward SR, Lieber RL. Scaling of muscle architecture and fiber types in the rat hindlimb. J Exp Biol. 2008;211(14):2336-45.
- Pulipati VP, Davidson MH. How I treat statin-associated side effects in an outpatient setting. Future Cardiol. 2021;17(7):1249-60.
- Vaughan CJ, Gotto AM, Jr. Update on statins: 2003. Circulation. 2004;110(7):886-92.
- Mokhmer S, Saber E, Hamouda A, Rifaai R. Structural Changes in the Skeletal Muscle Fiber of Adult Male Albino Rat Following Atorvastatin Treatment; the Possible Mechanisms of Atorvastatin Induced Myotoxicity. J Cytol Histol. 2017;08.
|